Answers are grounded in this paper and cite their sources.
A potent inhibitor for bone resorption, the gem-bisphosphonate zoledronate, has been chemically associated with calcium-deficient apatites. The ability of such materials to release the zoledronate, resulting in the inhibition of osteoclastic resorption, is demonstrated using a specific in-vitro bone resorption model. The resorption activity is typically characterized by the formation of lacunae on the surface of dentin slices (see Figure).
No takes yet. Share an insight, caveat, or question.
Josse et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: